Discharging a Patient on Anabolic Steroids
Patients on anabolic steroids should not be discharged without a thorough cardiovascular assessment and patient education about the risks of continued use, as these substances are associated with significant cardiovascular complications including hypertension and cardiomyopathy.
Risks of Anabolic Steroid Use
Anabolic-androgenic steroids (AAS) are associated with multiple serious adverse effects including cardiovascular disease, which may remain undetected for years 1
Cardiovascular risks include:
- Hypertension and heart failure with reduced ejection fraction 1
- Severe depression of high-density lipoprotein levels and increased low-density lipoprotein/cholesterol levels 2
- Increased risk of stroke, even in young athletes 2
- Alterations of the cardiovascular system that may be severe with prolonged use at high doses 3
Other significant health concerns include:
- Hepatic alterations ranging from abnormal liver function tests to life-threatening liver tumors, especially with 17-alpha-alkylated steroids 4
- Endocrine side effects including reproductive dysfunction in both sexes 4
- Psychological and behavioral disturbances, potentially including dependence with excessive doses 4, 3
Pre-Discharge Assessment
Before discharge, patients on anabolic steroids should be evaluated for:
Laboratory evaluation should include:
Discharge Considerations
If the patient has developed complications from anabolic steroid use:
For patients with severe complications:
Patient Education and Follow-up
Provide clear education about:
Establish a follow-up plan:
Special Considerations
- Athletes and bodybuilders may be resistant to discontinuing use due to performance concerns 5
- Patients may experience mild withdrawal effects upon discontinuation, though the dependence liability is relatively low compared to other substances 3
- Patients using anabolic steroids in combination with alcohol have an increased risk of violence and aggression, which may affect discharge safety planning 3
Conclusion
The decision to discharge a patient on anabolic steroids should be based on a thorough assessment of cardiovascular, hepatic, and psychological status. If significant complications are present, these should be addressed before discharge. All patients should receive education about the risks of continued use and appropriate follow-up care.